Get startedLog in
    Picture of Centessa Pharmaceuticals logo

    CNTA — Centessa Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Nxera To Receive Us$4.8 Mn In Milestone Payments Following Centessa's Initiation Of Clinical Development Of Orx142, A Novel Ox2r Agonist

    Picture of Centessa Pharmaceuticals logoCentessa Pharmaceuticals
    04/07/2025 01:02
    July 4 (Reuters) - Centessa Pharmaceuticals PLC 260y.F:

NXERA PHARMA CO LTD: NXERA TO RECEIVE US$4.8 MN IN MILESTONE PAYMENTS FOLLOWING CENTESSA'S INITIATION OF CLINICAL DEVELOPMENT OF ORX142, A NOVEL OX2R AGONIST

Source text: ID:nTSsc7c084

Further company coverage: [260y.F]

 (Reporting by Tokyo Newsroom)

 ((+81345201189;))

    Recent news on Centessa Pharmaceuticals

    See all news